Iterum Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Iterum Therapeutics stock has a target of 9.00, which predicts a 1,224.89% increase from the current stock price of 0.68.

Price Target: $9.00 (+1,224.89%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$9.00	$9.00	$9.00
Change	+1224.9%	+1224.9%	+1224.9%	+1224.9%

* Price targets were last updated on May 8, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Iterum Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	1	2	2	2	2	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $9	Strong Buy	Initiates	$9	+1,224.89%	May 8, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+636.05%	Sep 10, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $6 → $5	Strong Buy	Maintains	$6 → $5	+636.05%	Aug 15, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+783.26%	Jun 21, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+783.26%	May 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.86M

Revenue Next Year

16.63M

from 2.86M

482.25%

from 2.86M

EPS This Year

-0.38

from -1.26

EPS Next Year

-0.05

from -0.38

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	2.86M	16.63M
Revenue Growth	-	-	-	-	-	-	482.25%
EPS	-32.49	-8.41	-3.63	-2.96	-1.26	-0.38	-0.05
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	5.9M	18.4M
Avg	2.9M	16.6M
Low	n/a	14.8M

Revenue Growth

Revenue Growth	2025	2026
High	-	543.6%
Avg	-	482.2%
Low	-	418.1%

EPS Forecast

EPS	2025	2026
High	-0.22	0.11
Avg	-0.38	-0.05
Low	-0.53	-0.19

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.